buthionine sulfoximine has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, JK; Butterfield, DA; Chinta, SJ; Rajagopalan, S | 1 |
| Dringen, R; Eblen, F; Klockgether, T; Löschmann, PA; Schmid, A; Schulz, JB; Turski, L; Wüllner, U | 1 |
2 other study(ies) available for buthionine sulfoximine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
In vitro and in vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: relevance to the role of glutathione in Parkinson's disease.
Topics: Analysis of Variance; Animals; Buthionine Sulfoximine; Cell Line; Chromatography, High Pressure Liquid; Dipeptides; Disease Models, Animal; Drug Interactions; Enzyme Inhibitors; Glutathione; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Rats; Tyrosine 3-Monooxygenase | 2006 |
Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Buthionine Sulfoximine; Dopamine Agents; Glutathione; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1996 |